Abstract
The recent developments in cryo-EM have revolutionized our access to previously refractory structures. In particular, such studies of mammalian mitoribosomes have confirmed the absence of any 5S rRNA species and revealed the unexpected presence of a mitochondrially encoded tRNA (mt-tRNA) that usurps this position. Although the cryo-EM structures resolved the conundrum of whether mammalian mitoribosomes contain a 5S rRNA, they introduced a new dilemma -why do human and porcine mitoribosomes integrate contrasting mt-tRNAs?
Human mitoribosomes have been shown to integrate mt-tRNA Val , compared to the porcine use of mt-tRNA Phe . We have explored this observation further. Our studies examine i) whether a range of mt-tRNAs are used by different mammals, or if the mttRNA selection is strictly limited to only these two species out of the twenty two tRNAs encoded by the mitochondrial genome (mtDNA); ii) if there is tissue-specific variation within a single organism and iii) what happens to the human mitoribosome when levels of the mt-tRNA Val are depleted.
Our data demonstrate that i) only mt-tRNA Val or mt-tRNA Phe are found in the mitoribosomes of five different mammals; ii) each mammal favours the same mttRNA in all tissue types and iii) strikingly, when steady state level of mt-tRNA
Val are reduced, human mitoribosome biogenesis displays an adaptive response by switching to the incorporation of mt-tRNA Phe to generate translationally competent machinery.
Significance Statement
Mammalian mitoribosomes are idiosyncratic. They have reversed the typical 70% RNA:30% protein ratio to generate a protein rich ribosome, which lacks the conventional 5S transcript as a third rRNA component. Recent sub-nm-resolution structures revealed a further unexpected eccentricity, the integration of a mitochondrially-encoded tRNA into the large-subunit structure. However, mt-tRNA selection varies with mt-tRNA Val integration into human mitoribosomes, compared to porcine mitoribosomes favouring mt-tRNA Phe . Our analysis of mitoribosomes from multiple tissues isolated from different mammals found that of the twenty-two mitochondrially-encoded tRNAs, only mt-tRNA Val or mt-tRNA Phe are incorporated. Further, there was no evidence of tissue-specific selectivity. Remarkably, human mitoribosomes can exhibit adaptive plasticity when mt-tRNA Val levels are severely depleted by selectively integrating mt-tRNA Phe instead, to generate translationally competent mitoribosomes.
\body Introduction
Mammalian mitoribosomes differ considerably from other ribosomes, primarily due to a reversed protein to RNA mass ratio, such that proteins predominate. Of the eighty known mitoribosomal proteins, thirty-six are mito-specific and lack bacterial orthologues, and those with orthologues often carry mito-specific extensions [1] . Further idiosyncrasies have been revealed by recent sub-nm resolution cryo-EM structures, which simultaneously resolved a long debated question concerning mitoribosomal rRNA content [1, 2] . Until recently, mammalian mitoribosomes were considered divergent by containing only one rRNA species per subunit, although the potential presence of the 5S species in the mitochondrial large subunit (mt-LSU) remained a contentious issue [3] . Recent data have shown that there is indeed a third RNA moiety present in mammalian mitoribosomes. It is not, however, a 5S species but a tRNA encoded by the mitochondrial genome (mtDNA) [1, 2, [4] [5] [6] . Interestingly, which tRNA was selected differed between mammalian species, with mt-tRNA
Val predominating in human mt-LSU in contrast to mt-tRNA Phe being selected for incorporation into the porcine mt-LSU ( Fig. 1 A, B) .
Since mammalian mtDNA encodes twenty two tRNAs [7] we sought to clarify whether incorporation into the mt-LSU is restricted to mt-tRNA Val and mt-tRNA Phe , or whether there is a more promiscuous use of mt-tRNAs in either a species-or tissuespecific manner. Furthermore, we investigated the consequence of reduced mttRNA Val levels upon human mitoribosomes.
Results and Discussion

Do other mammals integrate other different mitochondrially encoded tRNAs into their mitoribosomes ?
Since the overall structure of tRNAs is generically considered to be similar, the level of discrimination displayed in the selection of mt-tRNA was perhaps surprising. To identify whether there was a process that integrated mitochondrially encoded tRNAs, other than -tRNA Val or -tRNA Phe into the central protuberance of mammalian mitoribosomes, we investigated the mt-tRNA content of porcine, human, bovine and rat mt-LSUs. Sucrose gradient separation of cell lysates facilitated analysis of the distribution of RNA and mt-LSU proteins within different fractions (Fig. S1 A-C) . The predominant mt-tRNA co-migrating with porcine and bovine mt-LSUs was mt-tRNA Phe ( Fig. 1, C, E) , whereas mt-tRNA Val was dominant in humans and rats (Fig. 1, D, F) . The migration of other mt-tRNAs was determined, the positions of which are widely distributed across the encoding polycistronic transcript. None of these were substantially enriched amongst mt-LSU-specific fractions in any of the mammalian samples tested (Fig. 1, C 
-F). Our results indicate that only mt-tRNA
Val or mt-tRNA Phe are integrated into mammalian mitoribosomes.
Is there tissue-specific variation in the selection of mt-tRNA integration ?
Having demonstrated species-specific incorporation of either mt-tRNA Val or mttRNA Phe into mammalian mitoribosomes, we addressed whether within a single organism, there existed any tissue-specific variation. Mitoribosome sedimentation was performed for several mammalian tissues and the ratio of free versus mt-LSUbound mt-tRNA was quantified. Results indicated that mt-tRNA Phe was the principal tRNA in porcine mt-LSU of cardiac, hepatic, skeletal muscle, and dermal epithelium (Fig. 2 A) . Notably, a fraction of mt-tRNA
Val was also detected in porcine mt-LSU across the tissues analysed. By contrast, mt-tRNA Val was consistently the dominant tRNA in the human, macaque and rat mt-LSU across all tissues analyzed ( Fig. 2 B-D) . These data suggest that there is no tissue-specific incorporation of different mttRNAs into mitoribosomes.
Are the mt-tRNAs that are integrated as structural components post-transcriptionally modified ?
Mitochondrial tRNAs undergo extensive post-transcriptional nucleotide modification. The structural data identified that the mt-LSU-integrated mt-tRNAs were matured by the addition of CCA on the 3' terminus [6] . We therefore sought to determine whether any differences in nucleotide modification status existed between these free and mt-LSU-bound pools [8] . No changes in m 1 A9 modification were detected between the free vs integrated pools of human mt-tRNA Val (Fig. S2) . This is consistent with the mt-LSU structures ( Fig. 1) , where in order to integrate into the mt-LSU, mt-tRNAs adopt an L-shaped tertiary structure dependent on m 1 A9 [9] .
What happens to mitoribosome biogenesis if levels of mt-tRNA
Val are depleted ?
Despite mt-tRNAs comprising only ~10% of the mitochondrial genome more than 200 disease causing mutations have been reported in these genes [10, 11] . Amongst these pathogenic changes is a homoplasmic m.1624C>T mutation in the gene encoding mt-tRNA Val (MTTV). The consequence of this particular mutation is a destabilization of the tRNA structure, which results in significantly reduced steady state levels [12, 13] . These depleted levels of mt-tRNA
Val were assumed to be the cause of compromised mitochondrial translation in patient tissue and cell lines [13] . However, in light of the observation that mt-tRNA Val is a component of the mitoribosome, we sought to determine the effect of reduced mt-tRNA Val levels on mitoribosome formation.
Individual clonal lines were derived from a cybrid population that harboured the homoplasmic m.1624C>T mutation. To eliminate any conflicting contribution resulting from the aneuploid nature of 143B cells [14] , five clones were analyzed. All shared a consistent biochemical and molecular phenotype, including decreased steady state levels of mt-tRNA Val compared to the parental 143B cell line ( Fig. 3 depicts a representative clone). Experiments were designed to determine if the protein synthesis defect was predominantly caused by decreased amounts of mitoribosome due to the reduced levels of mt-tRNA Val , or if both mitoribosome biogenesis and translation elongation were compromised by the available mt-tRNA Val being distributed between integration into the mitoribosome and elongation, thus compromising both aspects of translation.
The redistribution of mt-tRNA Val within sucrose gradients of the m.1624C>T cybrid lines was striking. The detectable majority was shifted to the free fractions, compared to mt-LSU association in the 143B parental controls (Fig. 3, lanes 1-3; Fig.  S3 ). This was consistent with the majority of the available mt-tRNA Val being preferentially retained for use in elongation. Western blotting of the sucrose gradient fractions showed comparable levels and distribution of mitoribosomal proteins between the mutant and control lines. This indicated that the levels of mitoribosome were not directly proportional to the levels of mt-tRNA Val , despite this element normally being required as a structural component.
To examine whether the mitoribosomes had formed in the absence of any mttRNA component, we probed the distribution of the remaining mt-tRNAs. All mttRNAs were analyzed and retained the same profile in control and m.1624C>T cells, with the majority present in the fractions corresponding to the free pool, available for aminoacylation and elongation. The notable exception was mt-tRNA Phe , which in contrast to 143B parental controls, now showed a significant proportion that partitioned with the mt-LSU (Fig. 3, lanes 6-8; Fig. S3 ). These data revealed that when the steady state levels of mt-tRNA
Val are limiting, the human mitoribosome displays adaptive plasticity by integrating mt-tRNA Phe into the mt-LSU.
We have shown previously that the molecular and biochemical defects in m.1624C>T cell lines [12] , [13] can be partially overcome by increasing levels of the cognate aminoacyl tRNA synthetase, VARS2, which stabilizes the mt-tRNA Val [13] . Therefore, to investigate whether suppression of the defect, observed with VARS2 overexpression, was caused by the expected redistribution of mt-tRNA Val back into the mitoribosome, we analyzed independently-generated lines with or without exogenous VARS2 induction (Fig. S4) . Despite the increased availability of mttRNA Val , biogenesis of the mt-LSU appeared to be sensitive to the structural abnormality in the mutant mt-tRNA Val , as mt-tRNA Phe was preferentially retained in the mt-LSU (Fig. S4) . This data is consistent with the partial restoration of intraorganellar protein synthesis resulting from an increased pool of charged mt-tRNA Val being available for elongation. High resolution structures of mt-tRNAs, either in isolation or in complex with the mt-LSU, are currently lacking. It is, therefore, not possible to determine whether the preferential incorporation of mt-tRNA Phe into the mt-LSU results from a better physicochemical fit than for the mutated mt-tRNA Val . However, translationally active mitoribosomes are generated, irrespective of which mt-tRNA is integrated [13] .
Mammalian mitoribosomes have many features that make them distinct from other ribosomes, even when compared to mitochondrial ribosomes from other organisms. Until recently, the apparent lack of a 5S rRNA was actively debated, particularly considering the level of conservation in its sequence, structure, and presence within ribosomes [15] . Although the increased proportion of protein components in mammalian mitoribosomes is unusual, the substitution of the 5S for a tRNA is currently without precedent. The 5S rRNA conservation also extends to the location of its gene relative to other rRNA genes in the genome [16] . Intriguingly, an analogous gene arrangement is found in most mammalian mitochondrial genomes, such that the two mt-tRNAs, which substitute for the 5S moiety in the mitoribosome, flank the two mt-rRNA genes (Fig. S5) . This gene arrangement in mammalian mtDNA means that the polycistronic transcription unit encompassing both the 12S and 16S mt-rRNA, which is reportedly synthesized in a major excess over other units [17] , would always include both mt-tRNA Phe and mt-tRNA Val [18] . This infers stoichiometric availability of these RNA species for incorporation into mt-LSU. Our understanding of mitoribosome biogenesis is too rudimentary to identify when the mttRNA is incorporated but based on the positioning of the cleaved termini of the 16S and the mt-tRNA Val , it seems unlikely that a polycistronic element is incorporated into the mt-LSU and subsequently cleaved. The context for CCA addition once integrated in the mt-LSU would be very different to all the other mt-tRNAs, perhaps suggesting that this occurs prior to incorporation and therefore not when the mt-tRNA is part of a polycistronic unit. Since we know that certain mammals and, under certain circumstances, human mitoribosomes incorporate mt-tRNA Phe in preference to mt-tRNA Val , it seems unlikely that a ~2.5knt RNA would be associated with the assembling mt-LSU prior to a cleavage event that would release the required mttRNA Phe .
The mammalian mitoribosome has substituted an mtDNA-encoded -tRNA for the 5S rRNA as a third structural RNA component. It has been well documented that mitochondrial RNase P is a protein only complex that does not require RNA import into the mitochondrial matrix [19] . Together, these observations support the absence of a functional requirement for RNA import into mammalian mitochondria.
In summary, the structural evidence for mt-tRNA incorporation, and the conserved positions of mammalian mtDNA genes suggests an evolutionary significance of gene arrangement that would promote coordinated transcription of the RNA species destined to be structural components of the mt-LSU. The inclusion of two mt-tRNAs within this highly transcribed unit provides a degree of plasticity to the process of mitoribosome biogenesis, as seen by the differing usage between organisms and the adaptive response observed under conditions of limiting mttRNA
Val
. What controls the selection of a specific mt-tRNA, despite the relative similarities in structure, or whether other mt-tRNAs can be used when levels of both these species are limiting is yet to be determined.
Materials and Methods
Cell culture
All cell lines used in this study were standard, commercially available cell lines except for the m.1624C>T transmitochondrial cybrid 143B lines, which used cytoplasts from patient cell lines that were derived from donated tissue samples. Access to samples that were excess to diagnostic requirements and were approved for (100 µg/ml) were added to select for successful integration and retention of the VARS2 gene. VARS2 induction was achieved by addition of 1µg/ml tetracycline for 14 days.
Mitochondrial transcript analysis
Total RNA from the relevant tissues was extracted using TRIzol (ThermoFisher Scientific) and treated with Turbo DNase following manufacturer's protocols. Northern blot analysis was essentially as previously performed [20] , total RNA was resolved on 6 or 15% UREA-PAGE (mt-tRNAs), subjected to wet transfer in 2x SSC to a nylon membrane (MAGNEPROBE, 0.45µ, GE Healthcare or Genescreenplus, NEN DuPont). Following UV-Crosslinking (0.120 J), membranes were hybridized with radioactive probes, corresponding to mt-tRNAs, overnight at 65°C in 7% SDS and 0.25 M sodium phosphate buffer (pH 7.6), washed with 1x SSC (150 mM sodium chloride and 15 mM sodium citrate, pH 7.0) three times for 20 min and then three times with 1x SSC containing 0.1% SDS (20 min; 65°C). The membranes were exposed to a storage phosphor screen (GE Healthcare), visualized in using a Typhoon phosphorimaging system and quantified using ImageQuant software (Molecular Dynamics, GE Healthcare) or ImageJ (http://imagej.nih.gov/ij).
To analyse modifications RNA was extracted using Trizol reagent (ThermoFisher Scientific) following the manufacturers instructions from sucrose gradient fractions as indicated. The reverse transcription primer extension (RT-PEx) was as in [21] , the specific 5′ 32 P-labeled primer (0.1 pmol) was incubated with 0.5 -1 μg of the RNA isolated from sucrose gradient fractions and subjected to reverse transcription reactions as described by [22] . The reaction mixture was separated by 12.5% (vol/vol) PAGE containing 7 M urea and dried gels were exposed to a storage phosphor screen and scanned as above. The following primers were used in RTPEx:
mt-tRNA Val : 5'-GTAAGTTGGGTGCTTTGTGTT mt-tRNA Phe : 5'-TCAGTGTATTGCTTTGAGGAGGT Analysis of mitochondrial ribosomal protein profile on isokinetic sucrose density gradients Mitochondria were isolated from indicated tissues as previously described [23] . Cultured cells or mitochondria isolated from the tissues were lysed in buffer containing 50 mM Tris-HCl (pH 7.2), 1% Triton X-100, 10 mM Mg(OAc) 2 , 100 mM NaCl EDTA-free complete protease inhibitor (Roche), and 0.08 U/ml RNAsin (Promega). The lysates (0.7 mg and 0.1 mg of cell and mitochondrial lysates, respectively) were loaded on a linear sucrose gradient (2 ml 10-30% (v/v)) in 50 mM Tris-HCl (pH 7.2), 10 mM Mg(OAc) 2 , 80 mM NH 4 Cl, 0.1 M KCl, 1 mM PMSF and centrifuged for 2 h 15 min at 100 000 g max at 4°C (39,000 rpm, Beckman Coulter TLS-55 rotor). Fractions (15 x 100 μl) were collected and 10 μl aliquots were analyzed directly by western blotting with the following antibodies; bL12m (PTG labs 14795-1-AP), uL3m (Abcam ab39268), mS29 (Abcam ab11928), mS40 (PTG labs 16139-1-AP), uL11m (CST D68F2). . 2 Determination of tissue specific variation in mt-tRNA incorporation into the mammalian mt-LSU. Selected tissues and cultured cells isolated from (A) pig (heart, liver, skeletal muscle and dermal fibroblasts), (B) human (osteoblasts and embryonic kidney cells), (C) macaque (heart and liver) and (D) rat (heart, liver, skeletal muscle, brain and kidney) were analyzed to determine any tissue specific variation in mttRNA incorporation into the mt-LSU. Upon lysis, the samples were sedimented through sucrose gradients, followed by RNA extraction. RNA samples from fractions 1 and 2 (free pool) and fractions 10 and 11 (mt-LSU-associated) were subjected to northern blotting. Abundance of mt-tRNA 
